Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Gabitril approved in France as add-on therapy

June 28, 1996

Depakote receives FDA approval for new indication

June 28, 1996

Gensia's GP-3269 in phase I

June 28, 1996

TV-1901 demonstrates efficiency and safety

June 28, 1996

Brain monoamine partial agonists/antagonists claimed by Neurogen

June 28, 1996

DuPont Merck and Richwood enter marketing agreement

June 28, 1996

Fujisawa discloses bradykinin antagonists

June 28, 1996

Asahi Brewery discloses antioxidants

June 21, 1996

Schering AG claims AMPA antagonists for neurodegenerative disorders

June 21, 1996

Hoechst synthesizes NOS inhibitors

June 21, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...